Answers are grounded in this paper and cite their sources.
Bleeding or severe coagulopathy from inherited or iatrogenic coagulation defects can often be corrected by transfusion of specific factor deficiency. However, in some situations transfusional therapy can be augmented or avoided altogether by hemostatic drugs. Many hemostatic drugs have been evaluated, but only a few have proven clinical efficacy. This article will review the pharmacology and dosing of drugs commonly used for reversing anticoagulation and fibrinolysis.
No takes yet. Share an insight, caveat, or question.
Franck et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: